by Taylor Abarca | Jan 17, 2020 | Featured, Latest News, Patient Care
Debbie Garcia always dreamed of having a big family. “I already had two wonderful boys but I knew I wanted at least four more,” Debbie says. “My mother thought I was crazy!” Debbie Garcia When it came to start trying for baby number three, Debbie knew that something...
by David Kelly | Jan 15, 2020 | Latest News, Research
Iñigo San Millán, PhD A byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutated cell to become cancerous, according to new research from the University of Colorado Anschutz Medical Campus. The study was published Tuesday in...
by Richard Schulick | Jan 9, 2020 | Featured, Members
Richard Schulick, MD, MBA, Director, University of Colorado Cancer Center We used to define cancer by where it lives in the body – “lung cancer,” “breast cancer,” “prostate cancer,” etc. And the way we studied and treated the disease was compartmentalized, too, with...
by CU Cancer Center | Jan 6, 2020 | Latest News
On a mission to raise awareness about the importance of cervical cancer screening, Tracy Jimenez was generous enough to share her cervical cancer story with the CU Cancer Center: “The pain went on for months. Then a day before my 46th birthday, I...
by Taylor Abarca | Dec 30, 2019 | Featured, Latest News
As 2019 comes to an end we would like to do a recap of the top ten most popular blog posts from the year! All of us here at the University of Colorado Cancer Center sincerely appreciate our readers and are honored to keep you up to date with the latest from the CU...
by Garth Sundem | Dec 13, 2019 | Featured, Latest News
Robert C. Doebele, MD, PhD Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small...
